Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013)
Ani Pharmaceuticals (ANIP) posted Cash from Discontinued Operations of 44000.0 for Q4 2013, up 118.75% sequentially from 234624.0 in Q3 2013, and up 157.83% YoY from 17065.4 in Q4 2012.
Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends
Ani Pharmaceuticals has reported Cash from Discontinued Operations for 2 years, with the latest figure at 44000.0 in Q4 2013.
- Quarterly Cash from Discontinued Operations rose 157.83% year-over-year to 44000.0 in Q4 2013, while the trailing twelve-month figure through Dec 2014 was 266707.0 (up 5.45% YoY) and the FY2013 annual result came in at 195000.0, down 37.32% from the prior year.
- Cash from Discontinued Operations rose to 44000.0 in Q4 2013 per ANIP's latest filing, from 234624.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 44000.0 in Q4 2013 and troughed at 234624.0 in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 44,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Sep 30, 2013 | -234,624.00 |
| Sep 30, 2013 | -234,624.00 |
| Dec 31, 2012 | -76,083.00 |
| Dec 31, 2012 | -76,083.00 |
| Sep 30, 2012 | -15,363.00 |
| Sep 30, 2012 | -15,363.00 |